Clinical Excellence
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Clinical Excellence
-
DaVita Emphasizes Caring Behaviors at Annual Villagewide
At this year’s Villagwide event, DaVita recognized several teammates who model its Core Values and caring behaviors. While the Core Values provide a roadmap for which DaVita teammates interact…
-
DaVita Hospital Services awarded Ambulatory Care Accreditation from The Joint Commission
DaVita Hospital Services has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Care Accreditation by demonstrating continuous compliance with its performance standards. The…
-
Preventing Kidney Failure Through Awareness: Exploring Efforts to Mitigate Risks and Slow Disease Progression
In March, National Kidney Month (NKM) serves as an opportunity to take stock of the progress the health care community has made through joint efforts to reduce the number of lives impacted by…
-
Social Worker Leans on Personal Experience to Provide Patients with Dedicated Support Systems and Connection
Every day, Terry Weaver brings to life DaVita’s focus on high-quality, empathetic and personalized care through how he supports and guides social workers. A divisional lead social worker at…
-
DaVita Seeks to Transform Kidney Care Management With New CWOW™ Technology Platform
For years, DaVita has invested in and built technology that supports better care-delivery—such as OneView’s care documentation and access for nephrologists who round in DaVita® centers and…
